Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
- PMID: 32398875
- DOI: 10.1038/s41591-020-0901-9
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Abstract
Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19) severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells from patients with varying severity of COVID-19 and from healthy people by using single-cell RNA sequencing. Proinflammatory monocyte-derived macrophages were abundant in the bronchoalveolar lavage fluid from patients with severe COVID-9. Moderate cases were characterized by the presence of highly clonally expanded CD8+ T cells. This atlas of the bronchoalveolar immune microenvironment suggests potential mechanisms underlying pathogenesis and recovery in COVID-19.
Comment in
-
Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.Protein Cell. 2020 Sep;11(9):680-687. doi: 10.1007/s13238-020-00752-4. Protein Cell. 2020. PMID: 32671793 Free PMC article. No abstract available.
Similar articles
-
Single-cell landscape of immunological responses in patients with COVID-19.Nat Immunol. 2020 Sep;21(9):1107-1118. doi: 10.1038/s41590-020-0762-x. Epub 2020 Aug 12. Nat Immunol. 2020. PMID: 32788748
-
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.Immunity. 2020 Oct 13;53(4):864-877.e5. doi: 10.1016/j.immuni.2020.07.026. Epub 2020 Aug 4. Immunity. 2020. PMID: 32791036 Free PMC article.
-
Early Insights into Immune Responses during COVID-19.J Immunol. 2020 Aug 1;205(3):555-564. doi: 10.4049/jimmunol.2000526. Epub 2020 Jun 8. J Immunol. 2020. PMID: 32513850 Review.
-
COVID-19: a conundrum to decipher.Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378. Eur Rev Med Pharmacol Sci. 2020. PMID: 32495923
-
Coronavirus disease 2019: a clinical review.Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4585-4596. doi: 10.26355/eurrev_202004_21045. Eur Rev Med Pharmacol Sci. 2020. PMID: 32373999 Review.
Cited by
-
Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19.Front Immunol. 2024 Sep 4;15:1450380. doi: 10.3389/fimmu.2024.1450380. eCollection 2024. Front Immunol. 2024. PMID: 39295871 Free PMC article. Review.
-
Role of TOMM34 on NF-κB activation-related hyperinflammation in severely ill patients with COVID-19 and influenza.EBioMedicine. 2024 Sep 13;108:105343. doi: 10.1016/j.ebiom.2024.105343. Online ahead of print. EBioMedicine. 2024. PMID: 39276680 Free PMC article.
-
Comprehensive mapping of immune perturbations associated with aplastic anemia.Cell Biol Toxicol. 2024 Sep 13;40(1):75. doi: 10.1007/s10565-024-09914-0. Cell Biol Toxicol. 2024. PMID: 39269517 Free PMC article.
-
Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial.BMC Infect Dis. 2024 Sep 12;24(1):960. doi: 10.1186/s12879-024-09886-w. BMC Infect Dis. 2024. PMID: 39266946 Free PMC article. Clinical Trial.
-
FABP4 deficiency ameliorates alcoholic steatohepatitis in mice via inhibition of p53 signaling pathway.Sci Rep. 2024 Sep 10;14(1):21135. doi: 10.1038/s41598-024-71311-8. Sci Rep. 2024. PMID: 39256510 Free PMC article.
References
-
- Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-Infected mice. Cell Host Microbe 19, 181–193 (2016). - DOI
-
- Liu, L. et al. Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019). - DOI
-
- Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269–270 (2020). - DOI
-
- Morse, C. et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J. 54, 1802441 (2019). - DOI
-
- Reyfman, P. A. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 1517–1536 (2019). - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials